.gif)
MOST NOTEWORTHY: UBS AG, Ansys and AstraZeneca were today's noteworthy upgrades:
- Deutsche Bank upgraded shares of UBS AG (NYSE: UBS) to Buy from Hold after the company announced further write-downs and plans to boost capital.
- Jefferies upgraded shares of Ansys (NASDAQ: ANSS) to Buy from Hold as they like the Ansoft (NASDAQ: ANST) acquisition and feel yesterday's sell-off creates an attractive entry point.
- AstraZeneca (NYSE: AZN) was raised to Neutral from Underweight at JP Morgan following the positive Crestor study results.
OTHER UPGRADES:
- Piper raised Akamai (NASDAQ: AKAM) to Buy from Neutral.
- Goldman upgraded Hansen Natural (NASDAQ: HANS) to Buy from Neutral.
- Vertex Pharma (NASDAQ: VRTX) was raised to Market Perform from Underperform at Wachovia and to Outperform from Neutral at Baird.
Cramer on BloggingStocks: Don't paint everything with the jobs brush
Seven banks go up in smoke ahead of the holiday weekend
Sears offering hedge for consumers who lose their job -- good idea?
